The Study
Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice.
This study tested if blocking a muscle-limiting protein helped sick mice walk better and live longer. It found that it didn’t help much — but it only tested one kind of mouse with one treatment plan. That doesn’t mean it wouldn’t work in other animals or people.
Analysis score
Maximum 58 for a case-control study.
Where the score came from
Scientists tried to make the muscles of very sick baby mice stronger by blocking a protein called myostatin, which normally stops muscles from growing too big.
Where does this study sit?
Systematic Reviews & Meta-analyses
Max 100Randomized Trials
Max 90Cohort Studies
Max 72Case-Control
Max 58Cross-Sectional
Max 44Case Reports & Series
Max 30Expert Opinion
Max 516 / 100
Quality score
A snapshot of a population at a single point in time. Can identify correlations and prevalence, but cannot determine the direction of cause and effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1No, the muscle gains didn't help the mice survive or move better — and losing fat made them sicker, showing this approach could be harmful.
- 2Muscles got a little bigger (up to 74%) but the mice didn't move better or live longer.
- 3Fat stores dropped by 39–46%, and more mice died (lived 11 days vs.
- 413 days).
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Human molecular genetics
Year
2009
Authors
C. Sumner, Claribel D Wee, Leigh C. Warsing, Dong W. Choe, Andrew S Ng, C. Lutz, K. Wagner
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.